Community Web Version Now Available
Han Jonghyeon
Correction please? Mezzion Pharma will be attending to AHA(American Heart Association) in November this year for their phase 3 trial results. Strong BUY by Nomura, targeting the stock price, 190,000(KRW) Nomura will be setting up IR(Investor Relations) of Mezzion and other Korean prospective companies in New York, September 24,25 Mezzion's phase 3 trial is supported by NIH/PHN which probably give you the signal that the trial will be successful.
Aug 19, 2019 3:25 AM
2
0
Answers · 2
Mezzion Pharma will be attending the AHA(American Heart Association) in November this year for their phase 3 trial results. Nomura made a strong buy, targeting the stock price at 190,000(KRW). Nomura will be setting up IR(Investor Relations) for Mezzion and other Korean prospective companies in New York, September 24-25. Mezzion's phase 3 trial is supported by NIH/PHN which probably gives you the signal that the trial will be successful.
August 19, 2019
Han Jonghyeon
Language Skills
English, Korean
Learning Language
English